Graph Therapeutics
AustriaEntry
2024
Hold
2yr
Status
Active
Who owns Graph Therapeutics?
Graph Therapeutics is currently owned by Merantix Capital through Merantix Capital AI Fund (2026 vintage), since 2024. Across its history, Graph Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-03
Most recent investor
Merantix CapitalMerantix Capital AI Fund · 2026 · VC
2 ownership periods · full history below
Key facts
HQAustria
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2024 · present
Merantix CapitalActive
2024 · present(2yr) · Merantix Capital AI Fund · 2026 · VC
SquareOneActive
2025 · present(1yr) · SquareOne III · 2022 · VC
More from Merantix Capital AI Fund
Other portfolio companies in the same fund.
Germany
Switzerland
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Graph Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Graph Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Graph Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue